NeuroVive Establishes Subsidiary in Taiwan

摘要

NeuroVive has established a subsidiary in Taiwan, NeuroVive Pharmaceutical Asia, Inc. which has secured initial funding totalling US$ 3,255 million. The funding is sourced from Taiwanese investors, collaboration partner Foundation Asia Pacific Ltd and the parent company ahead of its potential IPO in Taiwan. The subsidiary strengthens the group's presence in Asia and will be the driver behind existing project in the region, while conducting its own research and development operations under license from the parent company.